Annual Current Liabilities
$8.47 M
+$4.99 M+143.28%
December 31, 2023
Summary
- As of February 8, 2025, CYTH annual total current liabilities is $8.47 million, with the most recent change of +$4.99 million (+143.28%) on December 31, 2023.
- During the last 3 years, CYTH annual current liabilities has risen by +$4.80 million (+130.57%).
- CYTH annual current liabilities is now at all-time high.
Performance
CYTH Current Liabilities Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
High & Low
Earnings dates
Quarterly Current Liabilities
$18.72 M
+$8.89 M+90.47%
September 30, 2024
Summary
- As of February 8, 2025, CYTH quarterly total current liabilities is $18.72 million, with the most recent change of +$8.89 million (+90.47%) on September 30, 2024.
- Over the past year, CYTH quarterly current liabilities has increased by +$10.25 million (+121.07%).
- CYTH quarterly current liabilities is now at all-time high.
Performance
CYTH Quarterly Current Liabilities Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
High & Low
Earnings dates
Current Liabilities Formula
Current Liabilities = Accounts Payable + Short-Term Debt + Accrued Expenses + Other Current Liabilities
CYTH Current Liabilities Trends
| PeriodPeriod | AnnualAnnual | QuarterlyQuarterly |
|---|---|---|
| 1 y1 year | +143.3% | +121.1% |
| 3 y3 years | +130.6% | +121.1% |
| 5 y5 years | +339.8% | +121.1% |
CYTH Current Liabilities Highs & Lows
| PeriodPeriod | Annual vs highAnnual vs high | Annual vs lowAnnual vs low | Quarter. vs highQuarter. vs high | Quarter. vs lowQuarter. vs low | |
|---|---|---|---|---|---|
| 3 y | 3-year | at high | +143.3% | at high | +790.7% |
| 5 y | 5-year | at high | +169.6% | at high | +790.7% |
| alltime | all time | at high | >+9999.0% | at high | >+9999.0% |
Cyclo Therapeutics Current Liabilities History
| Date | Annual | Quarterly |
|---|---|---|
| Sep 2024 | - | $18.72 M(+90.5%) |
| Jun 2024 | - | $9.83 M(+50.4%) |
| Mar 2024 | - | $6.54 M(-22.8%) |
| Dec 2023 | $8.47 M(+143.3%) | $8.47 M(+27.9%) |
| Sep 2023 | - | $6.62 M(+8.6%) |
| Jun 2023 | - | $6.10 M(+35.5%) |
| Mar 2023 | - | $4.50 M(+29.3%) |
| Dec 2022 | $3.48 M(-9.1%) | $3.48 M(+21.1%) |
| Sep 2022 | - | $2.88 M(+36.8%) |
| Jun 2022 | - | $2.10 M(-26.9%) |
| Mar 2022 | - | $2.88 M(-24.9%) |
| Dec 2021 | $3.83 M(+4.3%) | $3.83 M(+12.0%) |
| Sep 2021 | - | $3.42 M(+12.7%) |
| Jun 2021 | - | $3.04 M(-18.1%) |
| Mar 2021 | - | $3.71 M(+0.9%) |
| Dec 2020 | $3.67 M(+16.9%) | $3.67 M(-19.5%) |
| Sep 2020 | - | $4.56 M(+12.4%) |
| Jun 2020 | - | $4.06 M(+2.7%) |
| Mar 2020 | - | $3.95 M(+25.8%) |
| Dec 2019 | $3.14 M(+63.1%) | $3.14 M(+34.4%) |
| Sep 2019 | - | $2.34 M(-13.6%) |
| Jun 2019 | - | $2.70 M(+2.6%) |
| Mar 2019 | - | $2.64 M(+37.0%) |
| Dec 2018 | $1.93 M(+104.2%) | $1.93 M(+16.3%) |
| Sep 2018 | - | $1.65 M(+28.4%) |
| Jun 2018 | - | $1.29 M(+20.7%) |
| Mar 2018 | - | $1.07 M(+13.3%) |
| Dec 2017 | $943.00 K(+175.3%) | $943.00 K(-16.6%) |
| Sep 2017 | - | $1.13 M(+99.5%) |
| Jun 2017 | - | $566.40 K(+156.3%) |
| Mar 2017 | - | $221.00 K(-35.5%) |
| Dec 2016 | $342.50 K(-65.6%) | $342.50 K(-60.9%) |
| Sep 2016 | - | $875.90 K(-22.0%) |
| Jun 2016 | - | $1.12 M(+13.4%) |
| Mar 2016 | - | $990.60 K(-0.5%) |
| Dec 2015 | $995.10 K(+8.7%) | $995.10 K(-4.3%) |
| Sep 2015 | - | $1.04 M(+22.3%) |
| Jun 2015 | - | $850.10 K(-6.3%) |
| Mar 2015 | - | $907.10 K(-0.9%) |
| Dec 2014 | $915.10 K(+360.1%) | $915.10 K(+253.0%) |
| Sep 2014 | - | $259.20 K(+83.8%) |
| Jun 2014 | - | $141.00 K(-37.7%) |
| Mar 2014 | - | $226.40 K(+13.8%) |
| Dec 2013 | $198.90 K(-37.6%) | $198.90 K(+28.8%) |
| Sep 2013 | - | $154.40 K(-39.8%) |
| Jun 2013 | - | $256.50 K(-40.3%) |
| Mar 2013 | - | $429.80 K(+34.8%) |
| Dec 2012 | $318.80 K | $318.80 K(-38.2%) |
| Date | Annual | Quarterly |
|---|---|---|
| Sep 2012 | - | $515.50 K(-6.8%) |
| Jun 2012 | - | $553.00 K(-7.2%) |
| Mar 2012 | - | $596.20 K(-8.6%) |
| Dec 2011 | $652.50 K(+536.0%) | $652.50 K(+96.8%) |
| Sep 2011 | - | $331.60 K(+46.2%) |
| Jun 2011 | - | $226.80 K(+68.8%) |
| Mar 2011 | - | $134.40 K(+31.0%) |
| Dec 2010 | $102.60 K(+270.4%) | $102.60 K(+3.2%) |
| Sep 2010 | - | $99.40 K(+52.5%) |
| Jun 2010 | - | $65.20 K(-0.2%) |
| Mar 2010 | - | $65.30 K(+135.7%) |
| Dec 2009 | $27.70 K(-61.6%) | $27.70 K(-30.4%) |
| Sep 2009 | - | $39.80 K(-38.5%) |
| Jun 2009 | - | $64.70 K(-25.0%) |
| Mar 2009 | - | $86.30 K(+19.7%) |
| Dec 2008 | $72.10 K(-7.1%) | $72.10 K(-3.1%) |
| Sep 2008 | - | $74.40 K(+29.2%) |
| Jun 2008 | - | $57.60 K(-37.7%) |
| Mar 2008 | - | $92.50 K(+19.2%) |
| Dec 2007 | $77.60 K(+33.1%) | $77.60 K(+181.2%) |
| Sep 2007 | - | $27.60 K(+35.3%) |
| Jun 2007 | - | $20.40 K(-60.8%) |
| Mar 2007 | - | $52.10 K(-10.6%) |
| Dec 2006 | $58.30 K(+54.6%) | $58.30 K(+18.3%) |
| Sep 2006 | - | $49.30 K(-8.9%) |
| Jun 2006 | - | $54.10 K(-54.5%) |
| Mar 2006 | - | $118.80 K(+215.1%) |
| Dec 2005 | $37.70 K(-85.3%) | $37.70 K(-20.3%) |
| Sep 2005 | - | $47.30 K(-15.8%) |
| Jun 2005 | - | $56.20 K(-42.8%) |
| Mar 2005 | - | $98.20 K(-61.6%) |
| Dec 2004 | $255.80 K(+237.9%) | $255.80 K(-0.2%) |
| Sep 2004 | - | $256.40 K(-2.6%) |
| Jun 2004 | - | $263.30 K(+185.0%) |
| Mar 2004 | - | $92.40 K(+22.1%) |
| Dec 2003 | $75.70 K(+135.8%) | $75.70 K(+22.3%) |
| Sep 2003 | - | $61.90 K(+54.8%) |
| Jun 2003 | - | $40.00 K(-0.5%) |
| Mar 2003 | - | $40.20 K(+25.2%) |
| Dec 2002 | $32.10 K(-82.2%) | $32.10 K(-55.4%) |
| Sep 2002 | - | $72.00 K(-39.4%) |
| Jun 2002 | - | $118.80 K(-19.2%) |
| Mar 2002 | - | $147.00 K(-18.4%) |
| Dec 2001 | $180.20 K(-20.6%) | $180.20 K(-33.1%) |
| Sep 2001 | - | $269.40 K(-7.5%) |
| Jun 2001 | - | $291.40 K(-9.9%) |
| Mar 2001 | - | $323.50 K(+42.5%) |
| Dec 2000 | $227.00 K | $227.00 K(-10.2%) |
| Sep 2000 | - | $252.80 K |
FAQ
- What is Cyclo Therapeutics annual total current liabilities?
- What is the all time high annual current liabilities for Cyclo Therapeutics?
- What is Cyclo Therapeutics annual current liabilities year-on-year change?
- What is Cyclo Therapeutics quarterly total current liabilities?
- What is the all time high quarterly current liabilities for Cyclo Therapeutics?
- What is Cyclo Therapeutics quarterly current liabilities year-on-year change?
What is Cyclo Therapeutics annual total current liabilities?
The current annual current liabilities of CYTH is $8.47 M
What is the all time high annual current liabilities for Cyclo Therapeutics?
Cyclo Therapeutics all-time high annual total current liabilities is $8.47 M
What is Cyclo Therapeutics annual current liabilities year-on-year change?
Over the past year, CYTH annual total current liabilities has changed by +$4.99 M (+143.28%)
What is Cyclo Therapeutics quarterly total current liabilities?
The current quarterly current liabilities of CYTH is $18.72 M
What is the all time high quarterly current liabilities for Cyclo Therapeutics?
Cyclo Therapeutics all-time high quarterly total current liabilities is $18.72 M
What is Cyclo Therapeutics quarterly current liabilities year-on-year change?
Over the past year, CYTH quarterly total current liabilities has changed by +$10.25 M (+121.07%)